Evidence map›Paper›PMID 27480950›Full record

ReviewNature reviews. Urology2016

Medical expulsive therapy for ureteral stones: where do we go from here?

Bhaskar K Somani, Omar Aboumarzouk, Olivier Traxer, Joyce Baard, Guido Kamphuis, Jean de la Rosette

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Knowledge‑map Analysis of Ureteroscopy for Urolithiasis.Journal of multidisciplinary healthcare · 2024
    Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bhaskar K SomaniDepartment of Urology, University Hospital Southampton, Tremona Road, Southampton SO16 6YD, UK.
Omar AboumarzoukBristol Urological Institute, North Bristol NHS Trust, Southmead Hospital, Southmead Road, Bristol BS10 5NB, UK.
Olivier TraxerTenon University Hospital, Pierre and Marie Curie, University, 4 rue de la Chine, 75020 Paris, France.
Joyce BaardDepartment of Urology, AMC University Hospital, Meibergdreef 9, Amsterdam 1105AZ, Netherlands.
Guido KamphuisDepartment of Urology, AMC University Hospital, Meibergdreef 9, Amsterdam 1105AZ, Netherlands.
Jean de la RosetteDepartment of Urology, AMC University Hospital, Meibergdreef 9, Amsterdam 1105AZ, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite two decades of clinical use, the effectiveness of medical expulsive therapy (MET) for the noninvasive management of patients with ureteral stones has, in the past year, been called into in question. The primary aim of MET is to expedite stone passage, although it has also shown effectiveness in reducing time to stone passage, thus reducing the incidence of colic episodes, improving stone clearance and improving patients' quality of life. At least 11 systematic reviews and meta-analyses have been published showing clinical benefits of MET; however, the results of these analyses have been challenged by data from two randomized controlled, multicentre trials with large patient cohorts, thus providing higher quality evidence that MET is ineffective in patients with ureteral stones. Results of the various systematic reviews and meta-analyses have suggested that MET is effective, however, such analyses incorporate the biases and limitations of smaller cohort studies, resulting in their conclusions being based upon lower-quality evidence. Evidence for the use of MET for small (<5 mm) distal ureteral stones has weakened based on clinical trial data published in 2015. However, MET might remain effective in the management of larger ureteral stones (>5 mm).

Indexed as

Adrenergic alpha-1 Receptor AntagonistsCalcium Channel BlockersHumansPatient SelectionTreatment OutcomeUreteral CalculiUrological AgentsAdrenergic alpha-1 Receptor AntagonistsCalcium Channel BlockersUrological Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.